Jyoti Drug Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 5.00 M
About Jyoti Drug
Jyoti Drug Private Limited (JDPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2009 and has a history of 15 years and nine months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Sandeep Rungta, Balkishan Rungta, Nitu Rungta, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239MH2009PTC191731
- Company No.
191731
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2009
- Date of AGM
22 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jyoti Drug?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Rungta  | Director | 16-Apr-2009 | Current |
| Balkishan Rungta | Director | 16-Apr-2009 | Current |
| Nitu Rungta | Director | 17-Jan-2011 | Current |
| Rajendra Sharma | Director | 31-Oct-2012 | Current |
| Sanjay Sharma | Director | 31-Oct-2012 | Current |
Financial Performance of Jyoti Drug.
Enhance accessibility to Jyoti Drug's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jyoti Drug?
Unlock access to Jyoti Drug's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2011 | Punjab National Bank | ₹5.00 M | Open |
How Many Employees Work at Jyoti Drug?
Unlock and access historical data on people associated with Jyoti Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jyoti Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jyoti Drug's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.